메뉴 건너뛰기




Volumn 5, Issue FEB, 2015, Pages

The ever-expanding immunomodulatory role of calreticulin in cancer immunity

Author keywords

calreticulin; Complex formation; Immunogenic cell death; Immunomodulation; TNF; Tumor necrosis factor related apoptosis inducing ligand

Indexed keywords

ACTIN; CALRETICULIN; CASPASE 3; CASPASE 7; CASPASE 8; CD30 LIGAND; CD40 LIGAND; CD47 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 1C; CYTOSKELETON PROTEIN; DEATH RECEPTOR 5; EZRIN; MITOXANTRONE; PHOSPHATIDYLSERINE; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

EID: 84923573816     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2015.00035     Document Type: Article
Times cited : (43)

References (30)
  • 2
    • 84880507352 scopus 로고    scopus 로고
    • Calreticulin for better or for worse, in sickness and in health, until death do us part
    • Eggleton P, Michalak M. Calreticulin for better or for worse, in sickness and in health, until death do us part. Cell Calcium (2013) 54:126-31. doi: 10.1016/j.ceca.2013.05.006
    • (2013) Cell Calcium , vol.54 , pp. 126-131
    • Eggleton, P.1    Michalak, M.2
  • 4
    • 65349090158 scopus 로고    scopus 로고
    • C1q enhances IFN-gamma production by antigen-specific T cells via the CD40 costimulatory pathway on dendritic cells
    • Baruah P, Dumitriu IE, Malik TH, Cook HT, Dyson J, Scott D, et al. C1q enhances IFN-gamma production by antigen-specific T cells via the CD40 costimulatory pathway on dendritic cells. Blood (2009) 113:3485-93. doi:10.1182/blood-2008-06-164392
    • (2009) Blood , vol.113 , pp. 3485-3493
    • Baruah, P.1    Dumitriu, I.E.2    Malik, T.H.3    Cook, H.T.4    Dyson, J.5    Scott, D.6
  • 5
    • 84887513073 scopus 로고    scopus 로고
    • CD1d(hi)CD5(+) B cells differentiate into antibody-secreting cells under the stimulation with calreticulin fragment
    • Zhang T, Xia Y, Zhang L, Bao W, Hong C, Gao XM. CD1d(hi)CD5(+) B cells differentiate into antibody-secreting cells under the stimulation with calreticulin fragment. Protein Cell (2013) 4:872-81. doi:10.1007/s13238-013-3062-5
    • (2013) Protein Cell , vol.4 , pp. 872-881
    • Zhang, T.1    Xia, Y.2    Zhang, L.3    Bao, W.4    Hong, C.5    Gao, X.M.6
  • 6
    • 84894233720 scopus 로고    scopus 로고
    • Soluble calreticulin induces tumor necrosis factor-alpha (TNF-alpha) and interleukin (IL)-6 production by macrophages through mitogen-activated protein kinase (MAPK) and NFkappaB signaling pathways
    • Duo CC, Gong FY, He XY, Li YM, Wang J, Zhang JP, et al. Soluble calreticulin induces tumor necrosis factor-alpha (TNF-alpha) and interleukin (IL)-6 production by macrophages through mitogen-activated protein kinase (MAPK) and NFkappaB signaling pathways. Int J Mol Sci (2014) 15:2916-28. doi:10.3390/ijms15022916
    • (2014) Int J Mol Sci , vol.15 , pp. 2916-2928
    • Duo, C.C.1    Gong, F.Y.2    He, X.Y.3    Li, Y.M.4    Wang, J.5    Zhang, J.P.6
  • 8
    • 79952533264 scopus 로고    scopus 로고
    • Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress
    • Martins I, Kepp O, Schlemmer F, Adjemian S, Tailler M, Shen S, et al. Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress. Oncogene (2011) 30:1147-58. doi:10.1038/onc.2010.500
    • (2011) Oncogene , vol.30 , pp. 1147-1158
    • Martins, I.1    Kepp, O.2    Schlemmer, F.3    Adjemian, S.4    Tailler, M.5    Shen, S.6
  • 9
    • 84857997683 scopus 로고    scopus 로고
    • A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
    • Garg AD, Krysko DV, Verfaillie T, Kaczmarek A, Ferreira GB, Marysael T, et al. A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death. EMBO J (2012) 31:1062-79. doi:10.1038/emboj.2011.497
    • (2012) EMBO J , vol.31 , pp. 1062-1079
    • Garg, A.D.1    Krysko, D.V.2    Verfaillie, T.3    Kaczmarek, A.4    Ferreira, G.B.5    Marysael, T.6
  • 10
    • 34948820602 scopus 로고    scopus 로고
    • Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
    • Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med (2007) 13:1050-9. doi:10.1038/nm1622
    • (2007) Nat Med , vol.13 , pp. 1050-1059
    • Apetoh, L.1    Ghiringhelli, F.2    Tesniere, A.3    Obeid, M.4    Ortiz, C.5    Criollo, A.6
  • 11
    • 62049085194 scopus 로고    scopus 로고
    • Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death
    • Panaretakis T, Kepp O, Brockmeier U, Tesniere A, Bjorklund AC, Chapman DC, et al. Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. EMBO J (2009) 28:578-90. doi:10.1038/emboj.2009.1
    • (2009) EMBO J , vol.28 , pp. 578-590
    • Panaretakis, T.1    Kepp, O.2    Brockmeier, U.3    Tesniere, A.4    Bjorklund, A.C.5    Chapman, D.C.6
  • 12
    • 84894082895 scopus 로고    scopus 로고
    • Targeting of the tumor necrosis factor receptor superfamily for cancer immunotherapy
    • Bremer E. Targeting of the tumor necrosis factor receptor superfamily for cancer immunotherapy. ISRN Oncol (2013) 2013:371854. doi:10.1155/2013/371854
    • (2013) ISRN Oncol , vol.2013
    • Bremer, E.1
  • 13
    • 65449152836 scopus 로고    scopus 로고
    • Following TRAIL's path in the immune system
    • Falschlehner C, Schaefer U, Walczak H. Following TRAIL's path in the immune system. Immunology (2009) 127:145-54. doi:10.1111/j.1365-2567.2009.03058.x
    • (2009) Immunology , vol.127 , pp. 145-154
    • Falschlehner, C.1    Schaefer, U.2    Walczak, H.3
  • 14
    • 0033519303 scopus 로고    scopus 로고
    • Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: a novel mechanism for the antitumor effects of type I IFNs
    • Kayagaki N, Yamaguchi N, Nakayama M, Eto H, Okumura K, Yagita H. Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: a novel mechanism for the antitumor effects of type I IFNs. J Exp Med (1999) 189:1451-60. doi:10.1084/jem.189.9.1451
    • (1999) J Exp Med , vol.189 , pp. 1451-1460
    • Kayagaki, N.1    Yamaguchi, N.2    Nakayama, M.3    Eto, H.4    Okumura, K.5    Yagita, H.6
  • 15
    • 0033583433 scopus 로고    scopus 로고
    • Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL
    • Griffith TS, Wiley SR, Kubin MZ, Sedger LM, Maliszewski CR, Fanger NA. Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL. J Exp Med (1999) 189:1343-54. doi:10.1084/jem.189.8.1343
    • (1999) J Exp Med , vol.189 , pp. 1343-1354
    • Griffith, T.S.1    Wiley, S.R.2    Kubin, M.Z.3    Sedger, L.M.4    Maliszewski, C.R.5    Fanger, N.A.6
  • 16
    • 0032701696 scopus 로고    scopus 로고
    • Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
    • Fanger NA, Maliszewski CR, Schooley K, Griffith TS. Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J Exp Med (1999) 190:1155-64. doi:10.1084/jem.190.8.1155
    • (1999) J Exp Med , vol.190 , pp. 1155-1164
    • Fanger, N.A.1    Maliszewski, C.R.2    Schooley, K.3    Griffith, T.S.4
  • 17
    • 0036467427 scopus 로고    scopus 로고
    • Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice
    • Cretney E, Takeda K, Yagita H, Glaccum M, Peschon JJ, Smyth MJ. Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice. J Immunol (2002) 168:1356-61. doi:10.4049/jimmunol.168.3.1356
    • (2002) J Immunol , vol.168 , pp. 1356-1361
    • Cretney, E.1    Takeda, K.2    Yagita, H.3    Glaccum, M.4    Peschon, J.J.5    Smyth, M.J.6
  • 18
    • 35348996565 scopus 로고    scopus 로고
    • Interaction of calreticulin with CD40 ligand, TRAIL and Fas ligand
    • Duus K, Pagh RT, Holmskov U, Hojrup P, Skov S, Houen G. Interaction of calreticulin with CD40 ligand, TRAIL and Fas ligand. Scand J Immunol (2007) 66:501-7. doi:10.1111/j.1365-3083.2007.01999.x
    • (2007) Scand J Immunol , vol.66 , pp. 501-507
    • Duus, K.1    Pagh, R.T.2    Holmskov, U.3    Hojrup, P.4    Skov, S.5    Houen, G.6
  • 19
    • 77957682653 scopus 로고    scopus 로고
    • Extracellular calreticulin is present in the joints of patients with rheumatoid arthritis and inhibits FasL (CD95L)-mediated apoptosis of T cells
    • Tarr JM, Winyard PG, Ryan B, Harries LW, Haigh R, Viner N, et al. Extracellular calreticulin is present in the joints of patients with rheumatoid arthritis and inhibits FasL (CD95L)-mediated apoptosis of T cells. Arthritis Rheum (2010) 62:2919-29. doi:10.1002/art.27602
    • (2010) Arthritis Rheum , vol.62 , pp. 2919-2929
    • Tarr, J.M.1    Winyard, P.G.2    Ryan, B.3    Harries, L.W.4    Haigh, R.5    Viner, N.6
  • 20
    • 26844468253 scopus 로고    scopus 로고
    • Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte
    • Gardai SJ, McPhillips KA, Frasch SC, Janssen WJ, Starefeldt A, Murphy-Ullrich JE, et al. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell (2005) 123:321-34. doi:10.1016/j.cell.2005.08.032
    • (2005) Cell , vol.123 , pp. 321-334
    • Gardai, S.J.1    McPhillips, K.A.2    Frasch, S.C.3    Janssen, W.J.4    Starefeldt, A.5    Murphy-Ullrich, J.E.6
  • 21
    • 49949115791 scopus 로고    scopus 로고
    • The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death
    • Panaretakis T, Joza N, Modjtahedi N, Tesniere A, Vitale I, Durchschlag M, et al. The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death. Cell Death Differ (2008) 15:1499-509. doi:10.1038/cdd.2008.67
    • (2008) Cell Death Differ , vol.15 , pp. 1499-1509
    • Panaretakis, T.1    Joza, N.2    Modjtahedi, N.3    Tesniere, A.4    Vitale, I.5    Durchschlag, M.6
  • 22
    • 84856696459 scopus 로고    scopus 로고
    • Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin
    • Garg AD, Krysko DV, Vandenabeele P, Agostinis P. Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin. Cancer Immunol Immunother (2012) 61:215-21. doi:10.1007/s00262-011-1184-2
    • (2012) Cancer Immunol Immunother , vol.61 , pp. 215-221
    • Garg, A.D.1    Krysko, D.V.2    Vandenabeele, P.3    Agostinis, P.4
  • 23
    • 78549274417 scopus 로고    scopus 로고
    • Melanoma-associated chondroitin sulfate proteoglycan (MCSP)-targeted delivery of soluble TRAIL potently inhibits melanoma outgrowth in vitro and in vivo
    • de Bruyn M, Rybczynska AA, Wei Y, Schwenkert M, Fey GH, Dierckx RA, et al. Melanoma-associated chondroitin sulfate proteoglycan (MCSP)-targeted delivery of soluble TRAIL potently inhibits melanoma outgrowth in vitro and in vivo. Mol Cancer (2010) 9:301. doi:10.1186/1476-4598-9-301
    • (2010) Mol Cancer , vol.9 , pp. 301
    • de Bruyn, M.1    Rybczynska, A.A.2    Wei, Y.3    Schwenkert, M.4    Fey, G.H.5    Dierckx, R.A.6
  • 24
    • 79952663868 scopus 로고    scopus 로고
    • Investigations on the C1q-calreticulin-phosphatidylserine interactions yield new insights into apoptotic cell recognition
    • Paidassi H, Tacnet-Delorme P, Verneret M, Gaboriaud C, Houen G, Duus K, et al. Investigations on the C1q-calreticulin-phosphatidylserine interactions yield new insights into apoptotic cell recognition. J Mol Biol (2011) 408:277-90. doi:10.1016/j.jmb.2011.02.029
    • (2011) J Mol Biol , vol.408 , pp. 277-290
    • Paidassi, H.1    Tacnet-Delorme, P.2    Verneret, M.3    Gaboriaud, C.4    Houen, G.5    Duus, K.6
  • 25
    • 53149137847 scopus 로고    scopus 로고
    • ERP57 membrane translocation dictates the immunogenicity of tumor cell death by controlling the membrane translocation of calreticulin
    • Obeid M. ERP57 membrane translocation dictates the immunogenicity of tumor cell death by controlling the membrane translocation of calreticulin. J Immunol (2008) 181:2533-43. doi:10.4049/jimmunol.181.4.2533
    • (2008) J Immunol , vol.181 , pp. 2533-2543
    • Obeid, M.1
  • 26
    • 78650664067 scopus 로고    scopus 로고
    • Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47
    • Chao MP, Jaiswal S, Weissman-Tsukamoto R, Alizadeh AA, Gentles AJ, Volkmer J, et al. Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47. Sci Transl Med (2010) 2:63ra94. doi:10.1126/scitranslmed.3001375
    • (2010) Sci Transl Med , vol.2 , pp. 63ra94
    • Chao, M.P.1    Jaiswal, S.2    Weissman-Tsukamoto, R.3    Alizadeh, A.A.4    Gentles, A.J.5    Volkmer, J.6
  • 27
    • 67650646082 scopus 로고    scopus 로고
    • CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis
    • Jaiswal S, Jamieson CH, Pang WW, Park CY, Chao MP, Majeti R, et al. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell (2009) 138:271-85. doi:10.1016/j.cell.2009.05.046
    • (2009) Cell , vol.138 , pp. 271-285
    • Jaiswal, S.1    Jamieson, C.H.2    Pang, W.W.3    Park, C.Y.4    Chao, M.P.5    Majeti, R.6
  • 28
    • 20444452880 scopus 로고    scopus 로고
    • Surface calreticulin mediates muramyl dipeptide-induced apoptosis in RK13 cells
    • Chen D, Texada DE, Duggan C, Liang C, Reden TB, Kooragayala LM, et al. Surface calreticulin mediates muramyl dipeptide-induced apoptosis in RK13 cells. J Biol Chem (2005) 280:22425-36. doi:10.1074/jbc.M413380200
    • (2005) J Biol Chem , vol.280 , pp. 22425-22436
    • Chen, D.1    Texada, D.E.2    Duggan, C.3    Liang, C.4    Reden, T.B.5    Kooragayala, L.M.6
  • 30
    • 10344260656 scopus 로고    scopus 로고
    • TRAIL-R as a negative regulator of innate immune cell responses
    • Diehl GE, Yue HH, Hsieh K, Kuang AA, Ho M, Morici LA, et al. TRAIL-R as a negative regulator of innate immune cell responses. Immunity (2004) 21:877-89. doi:10.1016/j.immuni.2004.11.008
    • (2004) Immunity , vol.21 , pp. 877-889
    • Diehl, G.E.1    Yue, H.H.2    Hsieh, K.3    Kuang, A.A.4    Ho, M.5    Morici, L.A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.